Eli Lilly’s Mounjaro targets India’s $150 billion weight-loss market amid rising diabetes crisis
Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...
Amy Schumer has spoken out about her Ozempic experience, and explained the 'red flags' she experienced with the drug.
First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results